Non-antibiotic methods to cure recurrent C. difficile colitis
Interviewed by Steven E Greer, MD
Vincent Young, MD PhD, infectious disease specialist from The University of Michigan discusses fecal transplantation (or transfer) to treat recurrent C. difficile colitis. Pseudomembranous colitis kills at least 16,000 patient per year in the U.S., and extends hospital stay in another 500,000, adding several billion in cost to the healthcare system.
In the second part, Dr. Young mentions new therapies in clinical trials to treat C. diff Pseudomembranous colitis including, monocloncal antibodies against the toxin, vaccines to rev up the immune system, and strains of C. diff. that do not produce the toxin.
No Comments
No comments yet.
Notice: comments_rss_link is deprecated since version 2.5! Use post_comments_feed_link() instead. in /data/30/1/121/80/1121895/user/1185656/htdocs/wordpress/wp-includes/functions.php on line 3406
RSS feed for comments on this post.
TrackBack URI